Anna-polina S. Shurygina

Saint Petersburg, SPE 197022, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Novel Intranasal Influenza-Vectored Vaccine Corfluvec Provides Protection Against Influenza and COVID-19, Mitigating SARS-CoV-2-Induced Lung Vascular Damage.

Novel Intranasal Influenza-Vectored Vaccine Corfluvec Provides Protection Against Influenza and COVID-19, Mitigating SARS-CoV-2-Induced Lung Vascular Damage.

Journal: Vaccines

Published: July 01, 2026

A CXCL10-Expressing Influenza Vector Induces Robust Adaptive Immunity Despite Strong Attenuation.

A CXCL10-Expressing Influenza Vector Induces Robust Adaptive Immunity Despite Strong Attenuation.

Journal: Pharmaceutics

Published: May 15, 2026

Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus.

Neomycin Exhibits Immunomodulatory and Antiviral Activity Against Influenza B Virus.

Journal: Viruses

Published: March 12, 2026

Novel Intranasal Replication-Deficient NS1ΔC Flu Vaccine Confers Protection from Divergent Influenza A and B Viruses in Mice.

Novel Intranasal Replication-Deficient NS1ΔC Flu Vaccine Confers Protection from Divergent Influenza A and B Viruses in Mice.

Journal: Vaccines

Published: December 09, 2025

Influenza Vaccine Immunogenicity in Hemodialysis Patients.

Influenza Vaccine Immunogenicity in Hemodialysis Patients.

Journal: Vaccines

Published: December 01, 2025

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice.

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice.

Journal: Vaccines

Published: December 05, 2024

Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice.

Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice.

Journal: Vaccines

Published: December 03, 2024

TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.

TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.

Journal: Pharmaceutics

Published: April 30, 2024

How the immune mousetrap works: Structural evidence for the immunomodulatory action of a peptide from influenza NS1 protein.

How the immune mousetrap works: Structural evidence for the immunomodulatory action of a peptide from influenza NS1 protein.

Journal: Biophysical chemistry

Published: December 20, 2023

Mini-PCNL, micro-PCNL or RIRS: comparative efficacy and safety in renal stones up to 2 cm

Mini-PCNL, micro-PCNL or RIRS: comparative efficacy and safety in renal stones up to 2 cm

Journal: Urologiia (Moscow, Russia : 1999)

Published: October 18, 2023

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

Journal: International journal of molecular sciences

Published: June 15, 2023

Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.

Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.

Journal: International journal of molecular sciences

Published: March 31, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026